Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : J&J Covid-19 Vaccine Boosters Reportedly Receive FDA Authorization, Bloomberg Says

10/20/2021 | 04:57pm EST


ę MT Newswires 2021
All news about MODERNA, INC.
03:55pModerna to Test Variant-Specific Vaccine Candidate
DJ
03:32pModerna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
BU
01:52pADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
01:37pUS Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New COVID-19 Stra..
MT
01:31pCLOSE UPDATE : US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New C..
MT
01:22pDelta, Carnival fall; Moderna, Clorox rise
AQ
01:02pStocks tumble on new coronavirus variant fear
RE
12:07pCovid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
DJ
12:03pFDA Places Clinical Hold on Phase 3 Study for Ocugen COVID-19 Vaccine Covaxin
MT
11:03aModerna Up 23%, On Track for Largest Percent Increase Since March 2020 -- Data Talk
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 170 M - -
Net cash 2021 12 747 M - -
P/E ratio 2021 12,5x
Yield 2021 -
Capitalization 134 B 134 B -
EV / Sales 2021 6,93x
EV / Sales 2022 5,38x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 329,63 $
Average target price 272,53 $
Spread / Average Target -17,3%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.161.69%110 846
LONZA GROUP AG25.95%56 890
IQVIA HOLDINGS INC.48.11%50 694
SEAGEN INC.-1.11%31 671
CELLTRION, INC.-40.39%23 975
ALNYLAM PHARMACEUTICALS, INC.45.26%22 581